Priya Kumar, MBBS, MS, is a board certified hematologist-oncologist and a member of the faculty of the University of Minnesota's Department of Hematology, Oncology, and Transplantation. Dr. Kumar has experience in treating a wide variety of cancers and benign hematology with a special interest in breast cancer. Her understanding of the complexity of cancer care and treatment and the toll it takes on patients allows her to help them make informed decisions about their care and throughout the treatment process.
Dr. Kumar earned her medical degree from India and completed her internal medicine residency at the State University of New York Upstate Medical University in Syracuse, New York. I have lived in the Twin Cities since 2003 and completed a fellowship in hematology/oncology at the University of Minnesota. It was during her fellowship training that she became interested in clinical research and evaluating the efficacy and side effects of different therapies for cancer. This interest led to a master's degree in clinical research from the School of Public Health at the University of Minnesota. Dr. Kumar has presented her work at national meetings and published in journals such as Lung Cancer, the American Journal of Clinical Oncology, Biology of Blood and Marrow Transplantation, and the British Journal of Cancer.
Balkrishna Jahagirdar, MD, is a board certified medical oncologist-hematologist. He is on the faculty of the Department of Medicine at the University of Minnesota, and serves as a member of the Experimental Therapeutics Committee of the Alliance for Clinical Trials in Oncology to help design and conduct clinical trials of new cancer treatments throughout the country.
Dr. Jahagirdar has co-authored a book chapter in the Textbook of Malignant Hematology, and his research is published in prestigious journals, including Nature, the Journal of Clinical Investigation, Blood, Experimental Hematology, and Leukemia.
He is a recipient of several awards and honors, including the Clinical Excellence Award of the University of Minnesota, Outstanding Clinical Mentor Award, National Cancer Institute's MetroMinnesota Community Clinical Oncology Program-Silver Certificate for his contribution to clinical trials in oncology, and the Blood and Marrow Transplant Award.
Yan Ji, MD, is an oncologist/hematologist at HealthPartners Medical Group, Regions Hospital. Dr. Ji's special interests include solid tumors, and lung, breast, and gastrointestinal cancers. Her many years of cancer research in these areas have deepened her understanding of underlying mechanisms that translate to the best treatment for patients.
Rajini Katipamula-Malisetti, MD, has presented at ASCO and the Mayo Clinic on various oncologic topics. Her areas of interest include GI oncology, breast cancer, cancer genetics, and lung cancer. She is co-author of a number of research papers in such publications as the Journal of Clinical Oncology and Clinical Medicine.
Daniel Pease, MD, treats adult cancers and blood disease with an emphasis on immunotherapy and molecularly targeted therapy.
Melissa M. Sherman, MD, is a medical oncologist and hematologist, who treats a wide variety of cancers. However, her special interests involve cancers of the GI tract including colon, rectal, and pancreatic. Dr. Sherman's professional interests include working with breast, colorectal, and pancreatic cancer patients.
Charles Shideman, MD, PhD, is a board certified radiation oncologist at MRO Regions in St. Paul, which he joined in 2017. Dr. Shideman understands that each patient’s cancer fight is unique. Drawing upon his expertise in treating patients who are facing a wide range of cancers, Dr. Shideman is ready to employ his knowledge of cancer treatments and MRO’s advanced radiation equipment to achieve the best possible outcomes.
Dr. Shideman works closely with medical oncologists, surgeons, and other practitioners to provide customized treatment programs using state-of-the-art radiation therapy protocols.